| Financial Year |
March 31 2023 |
| Monetary Funds |
204,724,673.38 |
| Held-for-trading Financial Assets |
4,600,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
426,663,455.80 |
| Advances to Suppliers |
137,326,240.77 |
| Other Receivables |
12,064,504.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
473,230,022.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,040,330.10 |
| Total Current Assets |
1,284,358,268.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
47,500,000.00 |
| Long-term Equity Investment |
5,419,512.04 |
| Investment Properties |
-- |
| Fixed Assetes |
152,597,773.46 |
| Under-construction Projects |
3,294,840.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,282,874.66 |
| R&D expenses |
12,555,000.00 |
| Goodwill |
16,356,856.47 |
| Long-Term Deferred and Prepaid Expenses |
3,450,514.48 |
| Deferred Income Tax Assets |
13,595,239.83 |
| Other Non-Current Assets |
2,150,000.00 |
| Sub-Total of Non-Current Assets |
330,651,318.06 |
| Total Assets |
1,615,009,586.92 |
| Short-Term Loans |
130,098,847.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
166,775,850.44 |
| Accounts Payable |
306,515,738.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,213,837.42 |
| Taxes Payable |
13,061,224.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,041,852.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,517,738.06 |
| Other Current Liabilities |
16,352,151.60 |
| Sub-Total of Current Liabilities |
748,364,046.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,083,769.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,124,026.05 |
| Total Liabilities |
766,488,072.43 |
| Paid-In Capital(Or Share Stock) |
95,666,682.00 |
| Capital Surplus |
473,918,246.82 |
| Surplus Reserve |
32,980,891.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
242,801,339.60 |
| Minority Stockholder's Interest |
4,651,354.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
843,870,160.41 |
| Owner's Equity（Stockholder's Equity） |
848,521,514.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,615,009,586.92 |
